First of all, I would like to thank all members for their support, allowing me to take over from Chairman Wu Mingxian and serve as the Chairman of the 19th Taiwan Gastroenterological Medical Association to serve everyone. The Taiwan Gastroenterological Medical Association is one of the earliest sub-specialty medical societies established in China, with more than 2,500 members, making it a leader in terms of history and scale.

During my tenure as chairman, the society will deepen the training of young doctors, continue to strengthen international exchanges, and promote young doctors to the international stage in a planned way. Education is an important task of the society, and the training of young doctors must be further deepened. Talent cultivation includes technical training, knowledge training and research method training. The society will continue to organize various educational courses. In addition to general education courses, it also arranges advanced courses, which teach research methods, how to find research topics, etc. . The society holds two large-scale events every year, including the annual meeting in March and the Taiwan Digestive Medicine Week (TDDW) held in late September and early October. In fact, not only Taiwan has TDDW, Japan has JDDW, and South Korea has KDDW. Former Chairman Lin Zhaotang With the mediation of , the three countries jointly organize joint seminars, which are held in each country in turn every year. Senior doctors will lead young doctors to participate, expanding the opportunities for young doctors to participate in international conferences.

Since the society's exchanges with the international community have become quite stable, we must continue to find ways to hold large-scale international conferences in Taiwan to enhance the society's academic influence. The last time Taiwan held Asia Pacific Digestive Medicine Week (APDW) was in 2015. I look forward to striving to hold APDW in Taiwan during my term of office, attracting more experts from Asia, and even European and American countries to come to Taiwan to participate, conduct formal exchanges, and give full play to the academic power of the society. Influence and friendship with experts from various countries. International exchanges are very important, but domestic exchanges must also be strengthened. TDDW is to join the participation of other societies. However, when resources are limited, the integration of relevant societies is a direction that must be considered, and co-organizing seminars is an easier way to advance.

The operation of the society must be related to academics, and new knowledge must be created to be passed on to the next generation, and knowledge must be transformed into clinical methods of caring for patients. Taiwan’s research must rely on quality and excellence to succeed. Taiwan has very talented people who can come up with better strategies through brainstorming. The World Health Organization relies on Taiwan's experience in the natural history of hepatitis B to understand the circumstances under which medication can provide the greatest benefit to patients. Another example is that the gastric cancer prevention and treatment and colorectal cancer screening guidelines formulated by Taiwan have also been incorporated into the World Health Organization's guidelines. These are not only a demonstration of the excellent research results of the Society, but also the advantages that Taiwan has. They must continue to be strengthened to show that Taiwan and the Society are proud of research strength.

Artificial intelligence (AI) is developing rapidly and is often used in imaging. Gastrointestinal medicine performs many imaging examinations, including gastroscopy, colonoscopy, computed tomography, ultrasound, etc. Because AI is an extremely important auxiliary tool for digestive medicine, it is closely related to Cooperation within the industry is an important direction of development. Whether cooperating with the government or industry, the Institute must not rest on its laurels, but must extend outwards and carry out diversified development.

Another important task of the society is to cooperate with the government to exert greater influence. Policies affect many aspects, and the society looks forward to strengthening its connection with the government. In addition to assisting the government in implementing relevant policies, it can also participate in policy formulation, so that policies and clinical practice can be truly aligned. The government will consult the professional opinions of the society when formulating policies, and the society will provide evidence-based medical opinions, transform research results into policies, and implement them accordingly. In addition, cooperation with industry is also one of the key points.

The new government of President Lai Ching-te is about to take office. The new government strives to create a healthy Taiwan. Cancer is the top ten cause of death, many of which are related to digestive medicine. Controlling cancer can reduce mortality. The society is very happy to provide relevant opinions and work with the government. Build a healthy Taiwan. To reduce cancer mortality, the primary goal is early detection, and screening is an important method. National health insurance has clear regulations on liver cancer screening, which has been in place for many years and can detect liver cancer early. The team led by former Chairman Wu Mingxian continues to conduct Helicobacter pylori screening and treatment. The program in Matsu has proven that it can significantly reduce the incidence of gastric cancer. The government is also considering relaxing the conditions. In the future, even patients who have not received gastroscopy are expected to receive health insurance. Paid antibiotic treatment. In addition to reducing mortality through screening, providing good treatments to increase survival rates is another issue. There are many new drugs on the market for the treatment of advanced cancer. Take liver cancer as an example. In the past, nothing could be done about inoperable advanced liver cancer, and the patient’s survival period was only about three to six months. However, with the emergence of new immunotherapy and targeted drugs, In the market, the patient's survival time has been close to two years, which is a remarkable improvement. Because the cost of new cancer drugs is extremely high and there are many restrictions on health insurance, which affects patients' treatment effects, the Society will continue to present real-world data to fight for patients' rights to use drugs. If the government wants to achieve the goal of reducing cancer mortality by 30% in 2030, it needs to learn to cooperate with "frequent screening, extensive treatment, and strong medication" to control digestive tract cancer. In addition to continuing to deepen the existing development fields, the society must also develop new aspects. In addition to intestinal bacteria, nutritional medicine, including weight loss, there is also room for strength, giving digestive medicine more possibilities for development.

There are many things to learn, but these tasks cannot be completed by one person, but require the joint efforts of a team. In terms of the structure of the new team of the society, the secretary-general is appointed by Professor Liu Zhiming of National Taiwan University Hospital, an expert on Helicobacter pylori and gastric cancer. It also expands the participation of various medical systems and grassroots members, taking into account all aspects. In addition, the Society is also looking for young, energetic and enthusiastic new blood to join, to understand the operation of the Society, to prepare for taking on heavy responsibilities in the future, to achieve the purpose of inheritance, and to ensure the normal metabolism of the Society's operations. Inheritance is important, but so is innovation. We look forward to creating new mechanisms to allow Taiwan to be seen by the world and expand its influence.

Finally, on behalf of the 19th board of directors, deputy secretaries and secretaries of the society, I would like to express my highest respect and gratitude to all members.

On behalf of the Asia-Pacific Association for the Study of the Liver (APASL) and Chinese Foundation for Hepatitis Prevention and Control (CFHPC), we are delighted to invite you to join us in Beijing from 26-30 March 2025 for the 34th Annual Conference of APASL (APASL 2025 BEIJING).

Under the theme “Multidisciplinary Collaboration For Elimination & Cure”, the five-day scientific programme will embrace diverse topics, ranging from basic research to clinical management including drug discovery, interventional and surgical procedures, covering viral hepatitis to liver cancer. At the end of each day, there will be an interprofessional forum dedicated to enhancing communication among various disciplines. Additionally, joint symposium will be held to foster international collaboration, share experiences in prevention and build partnerships in support of national hepatitis policy-making towards elimination of viral hepatitis by 2030.

Apart from the invited lectures delivered by the renowned speakers from around the world, APASL 2025 BEIJING will feature proffered abstracts selected for oral, poster and award presentations. This is an excellent opportunity for the researchers and the industry professionals to showcase their research findings and ideas.

Beyond academic exchange, we will also have the opportunity to reconnect with old friends and make new ones at our traditional social event, “Culture Night”.

We cherish the wonderful memories of 2010, when the APASL Annual Conference was first held in mainland China, bringing together 4645 participants from worldwide. Over the past 15 years, we have made many valuable connections and fought against liver disease together. During the time, we have witnessed the introduction of DAAs for hepatitis C, immunotherapy for liver cancer and advanced interventional technologies for the diagnosis and treatment. The recent approval of the first drug for NASH by the FDA is a particularly exciting development. We are confident that this progress will continue in the years to come with our collective effort.

We look forward to welcoming you to Beijing for an unforgettable and productive conference. Together, let us collaborate, innovate, and strive towards the elimination and cure.

Dear Colleagues and Friends,

We are pleased to invite you to the Joint 2025 Canadian Digestive Diseases Week™ and Canadian Liver Meeting Conference (CDDW™-CLM), which will be held from February 28 to March 2, 2025, at the Québec City Convention Centre in beautiful Quebec, Canada.

This conference is a collaboration between the Canadian Association of Gastroenterology (CAG) and the Canadian Association for the Study of the Liver (CASL), along with their affiliates: the Canadian Network on Hepatitis C (CanHepC), the Canadian NASH Network (CanNASH), the Canadian Association of Hepatology Nurses (CAHN), and TRIANGLE. The Joint CDDW™-CLM Conference is the premier meeting for all members of the Canadian gastroenterology and hepatology communities, including trainees, nurses, and researchers.

As we approach CDDW’s 30th anniversary in 2026, we proudly recognize this year as the 30th annual CDDW since its inception in 1996. This milestone conference will feature keynote presentations, interactive small-group discussions, hands-on workshops, the Mentorship Café, and various networking and social events, such as the President’s Gala at Le Château Frontenac, a scenic historical venue in Quebec. Our esteemed speakers will share the latest research findings, clinical practices, and technological advancements. We believe the knowledge and insights presented will inspire future research and innovation in our fields.

In addition to the scientific sessions, we have organized networking events to facilitate connections, spark new ideas, and encourage collaborations. We urge you to take advantage of these opportunities to expand your professional network and share your experiences, as these interactions often lead to fruitful and inspiring conversations.

We are confident that CDDW™-CLM 2025 will provide valuable opportunities for professional growth, knowledge exchange, and collaboration within the Canadian gastroenterology and liver communities. We also encourage you to immerse yourself in Quebec City’s vibrant culture and attractions during your stay.

We cordially invite you to join us at CDDW™-CLM 2025 and we look forward to having you at a conference that promises to be engaging, productive, and memorable.

It is an honour to welcome you to the 17th hepatology and gastroenterology post graduate course and the 27th Egyptian workshop of therapeutic GI endoscopy. We look forward to making this not only a learning opportunity at EGH, but another memorable event, where the attendees will share knowledge with experts & rising stars in the field of gastroenterology, hepatology, and endoscopy who will deliver the latest. We promise you the most exciting hepatology, gastroenterology and endoscopy meeting in 2024. I appeal to all participants to become active and enthusiastic contributors to our event.

Dear Colleagues,

On the behalf of the Organizing Committee of ISGCON 2024, we cordially extend a warm invitation to you to participate in the 65th Annual Conference of the Indian Society of Gastroenterology (ISGCON 2024), at Varanasi from 4th December to 7th December 2024.

We expect, approximately, 2000-2500 delegates and a large number of International and National faculty to attend the Conference.

The academic programme is very interactive and covers all salient topics on different aspects of Gastroenterology, Hepatology and GI Endoscopy. The Conference will be a great academic feast.

The first day’s agenda is a Post Graduate Course, especially, designed for our

Post - Graduates colleagues.

Varanasi, the holy city of Lord Shiva, is located on the banks of the holy River Ganges. This city, being the oldest living city of the world, is also considered as the Cultural, Spiritual and Education capital of India.

Saints and visionaries like Tulsidas, Kabirdas, Ravidas lived in Varanasi and contributed to society through their knowledge that is relevant even today.

Lord Budha gave his first sermon at Sarnath, 11 kms away, after his enlightenment at Bodh Gaya.

Varanasi is the city of temples and you may find a temple every 100 meters. The famous temples include Kashi Vishwanath Temple, Sankat Mochan Mandir, Durga Temple, Tulsi Manas Mandir, Tridev Mandir and Vishwanath Temple.

Banaras Hindu University or BHU as it is popularly known, is one of the largest universities in South East Asia. It was founded by legendry Pt. Madan Mohan Malviya Ji in 1916 and has almost all departments and 5 institutes like IIT BHU, IMS BHU, IAS BHU, Management Institute and Institute of Sustainable Development.

Varanasi has now been transformed into a metro city with an much improved international airport, model train stations and smooth roads resulting in good connectivity with all the major cities of the country.

Varanasi is also a major center for different musical “Gharanas”. A long list of well known classical artistes like Pandit Ravi Shanker (Sitar), Pandit Kishan Mehraj (Tabla),

Bharat Ratna Bismillah Khan (Shehnai), Nirmala Devi (Vocal), Channu Lal Mishra

(Vocal), Rajan-Sajan (Vocal) have their origins here and also honed their talents in the narrow alleys of the city.

The city is world famous for its Banarasi sarees, carpets and handicrafts. It is also a city famous for its cuisine and street food like “kachori”, “chaat” and “thandai”.

In early December the weather will be balmy and extremely pleasant and we look forward to welcoming you to Varanasi for a grand academic feast and also for sampling and enjoying the myriad cultural and ethnic pleasures offered by the city.

Warm regards,

Dear colleagues,

On behalf of the Hellenic Society of Gastroenterology, we invite you with great pleasure, but also with a sense of responsibility, to our annual established meeting, in the context of the 44th Panhellenic Congress of Gastroenterology .

The 44th Panhellenic Congress of Gastroenterology will be held this year, in Athens , at the Divani Caravel Hotel , on November 28 – December 1, 2024 and, as always, we are committed to an excellent scientific result, worthy of the prestige and the remarkable journey of the Hellenic Gastroenterology Society .

The Congress will be attended by prominent and highly prestigious scientists and all the newest developments and directions in the field of Gastroenterology will be presented. Cutting-edge issues, diagnosis and treatment will be thoroughly discussed, with the aim of informing and exchanging scientific knowledge and experience, while Clinical Tutorials will be organized with the aim of acquiring skills in the application of current guidelines in clinical practice.

We invite you, therefore, to honor us with your presence, but also with the sending of your scientific works, so that together we can contribute to the holding of a Conference of high educational and research value.

We look forward to meeting again in Athens and look forward to another completely successful scientific Congress, which will contribute to the continuation of the vision of the Hellenic Gastroenterology Society .

We expect and expect your presence and active participation .

It had been 10 years since Bali last hosted the APDW, and I am delighted to welcome you back. The APDW 2024 will be held on November 21 to 24, 2024 at Bali Nusa Dua Convention Centre.

APDW 2024 will continue to reinforce the promotion and celebration of advancements in digestive studies. The congress will feature a meticulously curated scientific agenda, led by internationally-renowned speakers, accompanied by numerous interactive sessions and social events. This assures our participants the optimum platform for sharing knowledge and fostering personal development.

Prepare for an enriching experience that combines learning, networking, and the captivating charm of Bali's landscapes and culture. We look forward to seeing you in Bali!